These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 14760392)
1. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene. Sale S; Verschoyle RD; Boocock D; Jones DJ; Wilsher N; Ruparelia KC; Potter GA; Farmer PB; Steward WP; Gescher AJ Br J Cancer; 2004 Feb; 90(3):736-44. PubMed ID: 14760392 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells. Sale S; Tunstall RG; Ruparelia KC; Potter GA; Steward WP; Gescher AJ Int J Cancer; 2005 Jun; 115(2):194-201. PubMed ID: 15688382 [TBL] [Abstract][Full Text] [Related]
3. The Effect of 4'-hydroxy-3,4,5-trimetoxystilbene, the Metabolite of Resveratrol Analogue DMU-212, on Growth, Cell Cycle and Apoptosis in DLD-1 and LOVO Colon Cancer Cell Lines. Jozkowiak M; Skupin-Mrugalska P; Nowicki A; Borys-Wojcik S; Wierzchowski M; Kaczmarek M; Ramlau P; Jodynis-Liebert J; Piotrowska-Kempisty H Nutrients; 2020 May; 12(5):. PubMed ID: 32392733 [TBL] [Abstract][Full Text] [Related]
4. 3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model. Piotrowska-Kempisty H; Ruciński M; Borys S; Kucińska M; Kaczmarek M; Zawierucha P; Wierzchowski M; Łażewski D; Murias M; Jodynis-Liebert J Sci Rep; 2016 Sep; 6():32627. PubMed ID: 27585955 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol. Ma Z; Molavi O; Haddadi A; Lai R; Gossage RA; Lavasanifar A Cancer Chemother Pharmacol; 2008 Dec; 63(1):27-35. PubMed ID: 18286288 [TBL] [Abstract][Full Text] [Related]
6. Role of CYP1A1 in the biological activity of methylated resveratrol analogue, 3,4,5,4'-tetramethoxystilbene (DMU-212) in ovarian cancer A-2780 and non-cancerous HOSE cells. Piotrowska-Kempisty H; Klupczyńska A; Trzybulska D; Kulcenty K; Sulej-Suchomska AM; Kucińska M; Mikstacka R; Wierzchowski M; Murias M; Baer-Dubowska W; Kokot Z; Jodynis-Liebert J Toxicol Lett; 2017 Feb; 267():59-66. PubMed ID: 28049037 [TBL] [Abstract][Full Text] [Related]
7. Trans-3,4,5,4'-tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivo. Chen LK; Qiang PF; Xu QP; Zhao YH; Dai F; Zhang L Acta Pharmacol Sin; 2013 Sep; 34(9):1174-82. PubMed ID: 23770989 [TBL] [Abstract][Full Text] [Related]
8. Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue. Piotrowska H; Myszkowski K; Amarowicz R; Murias M; Kulcenty K; Wierzchowski M; Jodynis-Liebert J Toxicol In Vitro; 2013 Dec; 27(8):2127-34. PubMed ID: 24055891 [TBL] [Abstract][Full Text] [Related]
9. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Brown VA; Patel KR; Viskaduraki M; Crowell JA; Perloff M; Booth TD; Vasilinin G; Sen A; Schinas AM; Piccirilli G; Brown K; Steward WP; Gescher AJ; Brenner DE Cancer Res; 2010 Nov; 70(22):9003-11. PubMed ID: 20935227 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol analogue 3,4,4',5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells. Piotrowska H; Myszkowski K; Ziółkowska A; Kulcenty K; Wierzchowski M; Kaczmarek M; Murias M; Kwiatkowska-Borowczyk E; Jodynis-Liebert J Toxicol Appl Pharmacol; 2012 Aug; 263(1):53-60. PubMed ID: 22687606 [TBL] [Abstract][Full Text] [Related]
11. 3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen. Cichocki M; Baer-Dubowska W; Wierzchowski M; Murias M; Jodynis-Liebert J Mol Cell Biochem; 2014 Jun; 391(1-2):27-35. PubMed ID: 24522554 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Patel KR; Brown VA; Jones DJ; Britton RG; Hemingway D; Miller AS; West KP; Booth TD; Perloff M; Crowell JA; Brenner DE; Steward WP; Gescher AJ; Brown K Cancer Res; 2010 Oct; 70(19):7392-9. PubMed ID: 20841478 [TBL] [Abstract][Full Text] [Related]
14. Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of hepatocarcinogenesis. Piotrowska H; Kujawska M; Nowicki M; Petzke E; Ignatowicz E; Krajka-Kuźniak V; Zawierucha P; Wierzchowski M; Murias M; Jodynis-Liebert J Hum Exp Toxicol; 2017 Feb; 36(2):160-175. PubMed ID: 27048571 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Asensi M; Medina I; Ortega A; Carretero J; Baño MC; Obrador E; Estrela JM Free Radic Biol Med; 2002 Aug; 33(3):387-98. PubMed ID: 12126761 [TBL] [Abstract][Full Text] [Related]
16. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. Howells LM; Berry DP; Elliott PJ; Jacobson EW; Hoffmann E; Hegarty B; Brown K; Steward WP; Gescher AJ Cancer Prev Res (Phila); 2011 Sep; 4(9):1419-25. PubMed ID: 21680702 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of HPLC-MS/MS procedure for determination of 3,4,4',5-tetra-methoxystilbene (DMU-212) and its metabolites in ovarian cancer cells and culture medium. Klupczynska A; Sulej-Suchomska AM; Piotrowska-Kempisty H; Wierzchowski M; Jodynis-Liebert J; Kokot ZJ J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():30-35. PubMed ID: 28582662 [TBL] [Abstract][Full Text] [Related]
18. Enhanced biological activity of liposomal methylated resveratrol analog 3'-hydroxy-3,4,5,4'-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model. Nowicki A; Wawrzyniak D; Czajkowski M; Józkowiak M; Pawlak M; Wierzchowski M; Rolle K; Skupin-Mrugalska P; Piotrowska-Kempisty H Drug Deliv; 2022 Dec; 29(1):2459-2468. PubMed ID: 35892260 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol and cellular mechanisms of cancer prevention. Shukla Y; Singh R Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635 [TBL] [Abstract][Full Text] [Related]